ELN and BIIB Said No New Cases on PML in Crohn's and Rheumatoid Arthritis Patients
Tweet Send to a Friend
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced findings from their safety evaluation of TYSABRI ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
